Nanodiagnostics
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.1515/dx-2014-0055 |
Resumo: | Nanotechnology has provided a plethora of valuable tools that can be applied for the detection of biomolecules and analytes relevant for diagnosis purposes - nanodiagnostics. This surging new field of molecular diagnostics has been revolutionizing laboratory procedures and providing new ways to assess disease biomarkers with increased sensitivity. While most of the reported nanodiagnostics systems are proof-of-concepts that demonstrate their efficacy in the lab, several nanodiagnostics platforms have already matured to a level that open the way for effective translation to the clinics. Nanodiagnostics platforms (e.g., gold nanoparticles containing systems) have been remarkably useful for the development of molecular diagnosis strategies for DNA/RNA detection and characterization, including systems suitable for point-of-care. How near are nanodiagnostics to go from the bench to the bedside? |
id |
RCAP_57d2076239b255b022c785321be7756e |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/53588 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
NanodiagnosticsLeaving the research lab to enter the clinics?Gold nanoparticlesMolecular diagnosticsNanodiagnosticsNanotechnologyPoint-of-careHealth PolicyPublic Health, Environmental and Occupational HealthClinical BiochemistryBiochemistry, medicalMedicine (miscellaneous)SDG 3 - Good Health and Well-beingNanotechnology has provided a plethora of valuable tools that can be applied for the detection of biomolecules and analytes relevant for diagnosis purposes - nanodiagnostics. This surging new field of molecular diagnostics has been revolutionizing laboratory procedures and providing new ways to assess disease biomarkers with increased sensitivity. While most of the reported nanodiagnostics systems are proof-of-concepts that demonstrate their efficacy in the lab, several nanodiagnostics platforms have already matured to a level that open the way for effective translation to the clinics. Nanodiagnostics platforms (e.g., gold nanoparticles containing systems) have been remarkably useful for the development of molecular diagnosis strategies for DNA/RNA detection and characterization, including systems suitable for point-of-care. How near are nanodiagnostics to go from the bench to the bedside?DCV - Departamento de Ciências da VidaUCIBIO - Applied Molecular Biosciences UnitRUNBaptista, Pedro Viana2018-12-03T23:19:26Z2014-12-012014-12-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article5application/pdfhttps://doi.org/10.1515/dx-2014-0055eng2194-8011PURE: 6400571http://www.scopus.com/inward/record.url?scp=84973885168&partnerID=8YFLogxKhttps://doi.org/10.1515/dx-2014-0055info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:26:26Zoai:run.unl.pt:10362/53588Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:32:39.674893Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Nanodiagnostics Leaving the research lab to enter the clinics? |
title |
Nanodiagnostics |
spellingShingle |
Nanodiagnostics Baptista, Pedro Viana Gold nanoparticles Molecular diagnostics Nanodiagnostics Nanotechnology Point-of-care Health Policy Public Health, Environmental and Occupational Health Clinical Biochemistry Biochemistry, medical Medicine (miscellaneous) SDG 3 - Good Health and Well-being |
title_short |
Nanodiagnostics |
title_full |
Nanodiagnostics |
title_fullStr |
Nanodiagnostics |
title_full_unstemmed |
Nanodiagnostics |
title_sort |
Nanodiagnostics |
author |
Baptista, Pedro Viana |
author_facet |
Baptista, Pedro Viana |
author_role |
author |
dc.contributor.none.fl_str_mv |
DCV - Departamento de Ciências da Vida UCIBIO - Applied Molecular Biosciences Unit RUN |
dc.contributor.author.fl_str_mv |
Baptista, Pedro Viana |
dc.subject.por.fl_str_mv |
Gold nanoparticles Molecular diagnostics Nanodiagnostics Nanotechnology Point-of-care Health Policy Public Health, Environmental and Occupational Health Clinical Biochemistry Biochemistry, medical Medicine (miscellaneous) SDG 3 - Good Health and Well-being |
topic |
Gold nanoparticles Molecular diagnostics Nanodiagnostics Nanotechnology Point-of-care Health Policy Public Health, Environmental and Occupational Health Clinical Biochemistry Biochemistry, medical Medicine (miscellaneous) SDG 3 - Good Health and Well-being |
description |
Nanotechnology has provided a plethora of valuable tools that can be applied for the detection of biomolecules and analytes relevant for diagnosis purposes - nanodiagnostics. This surging new field of molecular diagnostics has been revolutionizing laboratory procedures and providing new ways to assess disease biomarkers with increased sensitivity. While most of the reported nanodiagnostics systems are proof-of-concepts that demonstrate their efficacy in the lab, several nanodiagnostics platforms have already matured to a level that open the way for effective translation to the clinics. Nanodiagnostics platforms (e.g., gold nanoparticles containing systems) have been remarkably useful for the development of molecular diagnosis strategies for DNA/RNA detection and characterization, including systems suitable for point-of-care. How near are nanodiagnostics to go from the bench to the bedside? |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-12-01 2014-12-01T00:00:00Z 2018-12-03T23:19:26Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.1515/dx-2014-0055 |
url |
https://doi.org/10.1515/dx-2014-0055 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2194-8011 PURE: 6400571 http://www.scopus.com/inward/record.url?scp=84973885168&partnerID=8YFLogxK https://doi.org/10.1515/dx-2014-0055 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
5 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137948426305536 |